This Synthetic Biology Company Is On The Cusp Of Using Live, Engineered Bacteria As A Cancer Drug Injecting mice with engineered, live bacteria has been shown to shrink cancer tumors. With trials underway to bring this immunotherapy solution to the clinic, Synlogic is paving the way for synthetic biology and living medicines to transform the landscape of healthcare and medicine.